During the last session, IGM Biosciences Inc (NASDAQ:IGMS)’s traded shares were 0.47 million, with the beta value of the company hitting 0.32. At the end of the trading day, the stock’s price was $9.40, reflecting an intraday gain of 22.88% or $1.75. The 52-week high for the IGMS share is $17.70, that puts it down -88.3 from that peak though still a striking 59.47% gain since the share price plummeted to a 52-week low of $3.81. The company’s market capitalization is $554.13M, and the average trade volume was 275.71K shares over the past three months.
IGM Biosciences Inc (NASDAQ:IGMS) trade information
IGM Biosciences Inc (IGMS) registered a 22.88% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 22.88% in intraday trading to $9.40, hitting a weekly high. The stock’s 5-day price performance is 30.56%, and it has moved by 1.40% in 30 days. Based on these gigs, the overall price performance for the year is -13.60%.
IGM Biosciences Inc (IGMS) estimates and forecasts
Statistics show that IGM Biosciences Inc has outperformed its competitors in share price, compared to the industry in which it operates. IGM Biosciences Inc (IGMS) shares have gone up 109.35% during the last six months, with a year-to-date growth rate more than the industry average at 31.42% against 12.90. In the rating firms’ projections, revenue will increase 42.70% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 760k as predicted by 8 analyst(s). Meanwhile, a consensus of 8 analyst(s) estimates revenue growth to 780k by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 1.64M and 448k respectively. In this case, analysts expect current quarter sales to shrink by -53.70% and then jump by 74.10% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -44.65%. While earnings are projected to return 33.23% in 2024.
IGMS Dividends
IGM Biosciences Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
